In this issue:
axSpA is common in patients with AAU and chronic back pain
Psychosocial and physical activity interventions improve fatigue
Higher risk of severe COVID-19 outcomes in patients with inflammatory diseases
COVID vaccines protect against death in patients with rheumatic diseases
Machine learning model to predict MDA in recent-onset PsA
Value of ultrasound in PsA classification
Clinical characteristics of potential “difficult-to-treat” patients with PsA
Long-term survival of biological therapy in psoriatic arthritis
Real-world switch from adalimumab to biosimilar is successful
SERENA: two-year data of secukinumab for PsA or AS
Secukinumab effective in real-world clinical practice
Please login below to download this issue (PDF)